MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
Author:
Funder
National Institutes of Health
Pablove Foundation
National Cancer Institute NCI NeXT program
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://insight.jci.org/articles/view/97941/files/pdf
Reference44 articles.
1. Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia
2. Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia;Brandao;Blood Cancer J,2013
3. UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
4. Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe −/− Mice
5. A role for Mer tyrosine kinase in αvβ5 integrin-mediated phagocytosis of apoptotic cells;Wu;J Cell Sci,2005
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14
2. MERTK Is a Potential Therapeutic Target in Ewing Sarcoma;Cancers;2024-08-12
3. MERTK Inhibition as a Targeted Novel Cancer Therapy;International Journal of Molecular Sciences;2024-07-12
4. MerTK Induces Dysfunctional Dendritic Cells by Metabolic Reprogramming;Cancer Immunology Research;2024-07-08
5. Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism;2024-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3